Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Ferraro

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Microbes and Infection|July 9, 2008
Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cellsIvan Tattoli, Luigi Lembo-Fazio, Giulia Nigro, et al.
Bioconjugate Chemistry|October 27, 2025
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural MesotheliomaRoberto Silvestri, Margherita Piccardi, Alessia Laurenza, et al.
Microbial Pathogenesis|July 23, 2018
Multi-drug resistant Pseudomonas aeruginosa nosocomial strains: Molecular epidemiology and evolutionSilvia Angeletti, Eleonora Cella, Mattia Prosperi, et al.
Journal of Neurology|January 26, 2021
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosisMatteo Lucchini, Luca Prosperini, Maria Chiara Buscarinu, et al.
Antioxidants & Redox Signaling|April 2, 2014
S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunctionCostanza Montagna, Giuseppina Di Giacomo, Salvatore Rizza, et al.
Aging|July 27, 2020
Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging miceEmanuela Agosti, Marilisa De Feudis, Elia Angelino, et al.
Iscience|May 7, 2020
Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1<sup>G93A</sup> Mice Predates Disease Onset and Is A Promising Therapeutic TargetSilvia Scaricamazza, Illari Salvatori, Giacomo Giacovazzo, et al.
Journal of Neurology|November 24, 2016
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosisLuca Prosperini, Francesco Saccà, Cinzia Cordioli, et al.
Multiple Sclerosis and Related Disorders|March 11, 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observationViola Baione, Marco Canevelli, Daniele Belvisi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Microbes and Infection|July 9, 2008
Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cellsIvan Tattoli, Luigi Lembo-Fazio, Giulia Nigro, et al.
Bioconjugate Chemistry|October 27, 2025
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural MesotheliomaRoberto Silvestri, Margherita Piccardi, Alessia Laurenza, et al.
Microbial Pathogenesis|July 23, 2018
Multi-drug resistant Pseudomonas aeruginosa nosocomial strains: Molecular epidemiology and evolutionSilvia Angeletti, Eleonora Cella, Mattia Prosperi, et al.
Journal of Neurology|January 26, 2021
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosisMatteo Lucchini, Luca Prosperini, Maria Chiara Buscarinu, et al.
Antioxidants & Redox Signaling|April 2, 2014
S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunctionCostanza Montagna, Giuseppina Di Giacomo, Salvatore Rizza, et al.
Aging|July 27, 2020
Both ghrelin deletion and unacylated ghrelin overexpression preserve muscles in aging miceEmanuela Agosti, Marilisa De Feudis, Elia Angelino, et al.
Iscience|May 7, 2020
Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1<sup>G93A</sup> Mice Predates Disease Onset and Is A Promising Therapeutic TargetSilvia Scaricamazza, Illari Salvatori, Giacomo Giacovazzo, et al.
Journal of Neurology|November 24, 2016
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosisLuca Prosperini, Francesco Saccà, Cinzia Cordioli, et al.
Multiple Sclerosis and Related Disorders|March 11, 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observationViola Baione, Marco Canevelli, Daniele Belvisi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigationDaniele Belvisi, Marco Canevelli, Viola Baione, et al.
Pageof 9